Aseana Properties Limited Fundamentals Datasheet and Stock Analysis


Aseana Properties Limited is a property development company. It is engaged in the acquisition, development and redevelopment of upscale residential, commercial, hospitality and healthcare projects in various cities of Malaysia and Vietnam. It invests in development projects at the pre-construction stage and also invests in projects in construction and newly completed projects. Its segments include Investment Holding Companies, which is engaged in investing activities; Ireka Land Sdn. Bhd., which develops Tiffani by i-ZEN; ICSD Ventures Sdn. Bhd., which owns and operates Harbour Mall Sandakan and Four Points by Sheraton Sandakan Hotel; Amatir Resources Sdn. Bhd., which develops SENI Mont' Kiara; Iringan Flora Sdn. Bhd., which owns and operates Aloft Kuala Lumpur Sentral Hotel; Urban DNA Sdn. Bhd., which develops The RuMa Hotel and Residences, and Hoa Lam-Shangri-La Healthcare Group, which is a developer of International Healthcare Park, and owns and operates City International Hospital.

  • Current Price:
  • Industry:
  • Sector:
     Real Estate
  • ISIN:
  • Market Sector:
  • Main Indices:
  • Country of register:
     Great Britain
  • Currency:
  • Shares in Issue:
  • Market Cap:
  • Date Listed:
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)


Activity Data Not Available

Company Information

Non-Executive Director: Christopher Henry Lovell, Helen Siu Ming Wong Monica Lai  Non-Executive Chairman: Nicholas Paris  Independent Director: Tom Holland  

Composite Ranking: 
Historic EPS Ranking: 
Forecast EPS Ranking: 
Price Relative Strength: 
Industry Strength: 
SMR Ranking: 
ROCE Ranking: 
Mkt Accumulation/Dist: 
Unbroken Annual EPS: 
Unbroken Interim EPS: 
PEG Current Ranking: 
PEG Forecast Ranking: 
PE Current Ranking: 
PE Forecast Ranking: 
Margin Current Ranking: 
Margin Forecast Ranking: 
Add Indicator


Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Operating Profit/(loss)$m33.67(12.74)(9.45)23.29(9.98)25.387.73(1.00)(24.94)
Profit Before Tax$m33.13(16.63)(18.80)15.41(20.65)16.16(4.33)(6.80)(28.66)
Profit After Tax$m14.14(18.43)(21.65)6.03(21.93)15.48(5.53)(6.41)(30.01)
Profit After Tax (from discontinued operations)$m0.
Overall Profit for the Period$m14.14(18.43)(21.65)6.03(21.93)15.48(5.53)(6.41)(30.01)
EPS Growth%
Earnings Per Share¢7.56(7.94)(8.96)4.29(7.44)8.89(1.98)(2.46)(13.64)
Op. Cash Flow P/S¢0.000.42(1.83)(1.50)(1.63)0.97(1.51)0.000.00
Cash Flow P/S Grth%(100.00)
Net Cash Flow P/S¢
Capital Exp P/S$
Tax Rate%
P/E Ratiox4.700.000.0010.500.005.800.000.000.00
P/E Growth$
Turnover Per Share$
Pre-Tax Profit / Share$
Operating Margin%0.00(53.68)(32.30)27.37(32.92)22.5523.04(3.03)(256.58)
Mkt Cap$m70.5478.9887.4289.4190.16103.32105.31107.7991.40
Dividend Per Share¢
DPS Growth%0.00(100.00)
Dividend Yield%2.800.
Dividend Coverx7.560.
Shareholder Funds$m203.37183.58158.57160.50130.16143.36142.53136.37109.65
Net Borrowings$m(32.61)(16.75)(24.58)(26.01)(22.98)(26.65)(25.98)(12.57)(7.61)
Net Assets$m207.65196.65170.00170.69131.60142.21142.86135.44105.80
Net Assets P/S$
Latest Forecast
Div Yield0.0%0.0%
Div Cover0.0%0.0%
Op Margin-256.6%0.0%
Director Deals
Traded Action Notifier Price Amount Value
06-Jan-17SellGerald Ong Chong Keng360.75 141,533$,106,149.75
06-Jan-17SellDavid Harris360.75 12,473ű,354.75
  Rows per page
199m    Major: 100%    Director: 0%
Notifier Holding Value
Christopher Henry Lovell48,000$153.60
  Rows per page
Gearing & Cover
News Title Date Time Source
Proposed demerger of certain assets07-May-2015:51RNS
Extension of Reporting Deadline30-Mar-2007:00RNS
Update on the impact of the Covid-19 virus23-Mar-2007:00RNS
Resignation of CEO09-Jan-2009:45RNS
Result of general meeting30-Dec-1913:56RNS
Notice of GM and Posting of Circular13-Dec-1907:00RNS
Appointment of New Broker15-Nov-1907:30RNS
Half-year Report27-Sep-1916:14RNS
Directorate Changes09-Sep-1907:00RNS
Temporary change to reporting timetable13-Aug-1907:09RNS
First PagePrev PageNext Page  Rows per page
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change
14-Nov-11Panmure GordonBuy37.50p0.00p0.00pReiteration
  Rows per page

This functionality requires you to login

Click here to login
Or register for a new account